These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21496630)

  • 1. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolinopathies: from the biology of caveolin-3 to human diseases.
    Gazzerro E; Sotgia F; Bruno C; Lisanti MP; Minetti C
    Eur J Hum Genet; 2010 Feb; 18(2):137-45. PubMed ID: 19584897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
    Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotonia associated with caveolin-3 mutation.
    Milone M; McEvoy KM; Sorenson EJ; Daube JR
    Muscle Nerve; 2012 Jun; 45(6):897-900. PubMed ID: 22581547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene.
    Catteruccia M; Sanna T; Santorelli FM; Tessa A; Di Giacopo R; Sauchelli D; Verbo A; Lo Monaco M; Servidei S
    Neuromuscul Disord; 2009 Nov; 19(11):779-83. PubMed ID: 19773168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
    Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
    Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new missense mutation in caveolin-3 gene causes rippling muscle disease.
    Dotti MT; Malandrini A; Gambelli S; Salvadori C; De Stefano N; Federico A
    J Neurol Sci; 2006 Apr; 243(1-2):61-4. PubMed ID: 16458928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-3 is a direct molecular partner of the Cav1.1 subunit of the skeletal muscle L-type calcium channel.
    Couchoux H; Bichraoui H; Chouabe C; Altafaj X; Bonvallet R; Allard B; Ronjat M; Berthier C
    Int J Biochem Cell Biol; 2011 May; 43(5):713-20. PubMed ID: 21262376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of a novel caveolin-3 mutation in a large German family.
    Fischer D; Schroers A; Blümcke I; Urbach H; Zerres K; Mortier W; Vorgerd M; Schröder R
    Ann Neurol; 2003 Feb; 53(2):233-41. PubMed ID: 12557291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel CAV3 gene mutations in Japanese families.
    Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
    Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy.
    Müller JS; Piko H; Schoser BG; Schlotter-Weigel B; Reilich P; Gürster S; Born C; Karcagi V; Pongratz D; Lochmüller H; Walter MC
    Neuromuscul Disord; 2006 Jul; 16(7):432-6. PubMed ID: 16730439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel missense mutation in the caveolin-3 gene in rippling muscle disease.
    Lorenzoni PJ; Scola RH; Vieira N; Vainzof M; Carsten AL; Werneck LC
    Muscle Nerve; 2007 Aug; 36(2):258-60. PubMed ID: 17405141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
    Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
    Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation.
    Madrid RE; Kubisch C; Hays AP
    Neurology; 2005 Oct; 65(8):1301-3. PubMed ID: 16247063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolinopathies in Greece.
    Papadopoulos C; Papadimas GK; Kekou K; Spengos K; Svigou M; Kitsiou-Tzeli S; Manta P
    Neurologist; 2015 Jul; 20(1):8-12. PubMed ID: 26185955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
    Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
    Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.